Archives

by in
Entry Author Date Location
Backed by Gates, Affinivax Ramps up Velcro-like Vaccine Tech 10/30/14 Boston
Try Then Buy? Sutro Deal Could Be Celgene’s Biggest Antibody Bet Yet 10/23/14 New York
East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More 10/16/14 Boston
What Seattle Needs (Part 3): Working Together to Revitalize Biotech 10/08/14 Seattle
What Seattle Needs (Part 2): Dealing With Amgen’s Upcoming Departure 10/07/14 Seattle
East Coast Biotech Roundup: Intarcia, Atlas, Visterra, & More 10/06/14 Boston
What Seattle Needs (Part 1): “Semi-Successful” Biotech Companies 10/06/14 Seattle
East Coast Biotech Roundup: GliaCure, Civitas, T2, & More 09/29/14 Boston
Blessed By Angels, GliaCure Tests New Alzheimer’s Approach In Humans 09/26/14 Boston
Cempra Milestone Highlights Experimental Antibiotic’s Potential 09/09/14 Raleigh Durham
East Coast Biotech Roundup: Infinity, Merck, Voyager, Ebola, & More 09/05/14 Boston
Merck, Leapfrogging Bristol-Myers, Wins FDA Nod for Cancer Drug 09/04/14 New York
West Coast Biotech Roundup: Mapp Bio, Calico, Alder, VentiRx & More 09/04/14 San Diego
Bristol-Myers Kicks Arthritis Drug Back to Alder, Shares Tumble 09/02/14 Seattle
Exelixis Axes 70% of Workforce as Cancer Drug Flops, Shares Routed 09/02/14 San Francisco
Roche To Pay $8.3B For Intermune: Who’s Next In Pulmonary Fibrosis? 08/25/14 San Francisco
East Coast Biotech Roundup: NJ Blues, Genzyme, Amicus, Biogen & More 08/25/14 Boston
Standing on a Ledge Once Again, Amicus Holds Breath for Latest Study 08/11/14 New York
Jounce Taps Merck Vet to Lead Cancer Drug Push 07/10/14 Boston
East Coast Biotech Roundup: Accelerate LI, ASCO, Akebia, & More 06/09/14 Boston
Merck Scoops Up Idenix in $3.85B Buyout 06/09/14 Boston
Jibe Using Data Analytics, New Cash to Shake Up Job Recruiting Scene 06/02/14 New York
East Coast Biotech Roundup: Bristol, PTC, Ophthotech, & More 05/27/14 Boston
East Coast Biotech Roundup: LTI, SolveBio, Proteon, & More 05/16/14 Boston
Celldex, Bristol-Myers Cut Deal on Immuno-Oncology Combo Trial 05/14/14 New York
East Coast Biotech Roundup: Mergers, Rhythm, Regeneron, & More 05/09/14 Boston
West Coast Biotech Roundup: Alder IPO, Exelixis, Corcept, and More 05/09/14 San Diego
Biotech IPO Slump Deepens as Alder Prices Below Range 05/08/14 Seattle
San Diego’s Ambrx Files for IPO to Advance Antibody-Drug Conjugates 05/05/14 San Diego
Seeking Tau: BMS Buys iPierian and Brain-Disease Program for $175M 04/29/14 San Francisco
Page 1 of 10 next page »